MET and non-small cell lung carcinoma: Garofalo et al. (2009) also proposed a mechanism of miR-221/222 upregulation in non-small cell lung cancer (NSCLC) and hepatocellular carcinoma (HCC) models involving c-MET/MET-mediated upregulation of the transcription factor AP-1 [25].